home / stock / rapt / rapt quote
Last: | $ |
---|---|
Change Percent: | -3.44% |
Open: | $31.42 |
Close: | $30.07 |
High: | $31.42 |
Low: | $29.60 |
Volume: | 304,090 |
Last Trade Date Time: | 02/12/2020 04:43:49 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $31.42 | $30.07 | $31.42 | $29.60 | 304,090 | 02-12-2020 |
$ | $32.38 | $31.14 | $33.24 | $30.13 | 94,826 | 02-11-2020 |
$ | $30.27 | $31.29 | $33.6437 | $30.00 | 135,340 | 02-10-2020 |
$ | $31.15 | $30.01 | $31.40 | $29.775 | 1,074,889 | 02-07-2020 |
$ | $34.16 | $33.61 | $34.55 | $27.86 | 106,036 | 02-06-2020 |
$ | $40.00 | $32.00 | $40.00 | $31.17 | 142,575 | 02-05-2020 |
$ | $42.52 | $42.36 | $44.995 | $42.00 | 15,963 | 02-04-2020 |
$ | $44.00 | $43.05 | $44.496 | $41.8765 | 22,651 | 02-03-2020 |
$ | $43.46 | $44.29 | $46.44 | $43.2501 | 20,240 | 01-31-2020 |
$ | $44.75 | $44.66 | $46.49 | $43.29 | 35,114 | 01-30-2020 |
$ | $45.45 | $45.19 | $46.24 | $44.10 | 44,495 | 01-29-2020 |
$ | $50.28 | $45.65 | $51.2095 | $44.55 | 56,676 | 01-28-2020 |
$ | $41.02 | $48.86 | $49.20 | $40.1201 | 53,126 | 01-27-2020 |
$ | $43.68 | $42.01 | $44.9988 | $41.32 | 28,721 | 01-24-2020 |
$ | $47.06 | $43.61 | $47.5565 | $41.9025 | 52,782 | 01-23-2020 |
$ | $44.94 | $47.2953 | $47.885 | $43.7489 | 59,705 | 01-22-2020 |
$ | $47.25 | $44.70 | $47.702 | $42.23 | 87,877 | 01-21-2020 |
$ | $47.02 | $47.39 | $49.06 | $42.17 | 125,761 | 01-20-2020 |
$ | $47.02 | $47.39 | $49.06 | $42.17 | 125,759 | 01-17-2020 |
$ | $37.10 | $46.96 | $47.095 | $37.10 | 183,998 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
RAPT Therapeutics Inc. Company Name:
RAPT Stock Symbol:
NYSE Market:
NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigat...
SOUTH SAN FRANCISCO, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflamm...
SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (NASDAQ:RAPT), a clinical-stage, immunology-based therap...